What's Happening?
Robbins LLP, a shareholder rights law firm, has announced a class action lawsuit against SelectQuote, Inc., an insurance broker that sells Medicare Advantage and other health insurance plans. The lawsuit, filed on behalf of investors who acquired SelectQuote securities between September 9, 2020, and May 1, 2025, alleges that the company violated the False Claims Act. The complaint accuses SelectQuote of steering Medicare beneficiaries towards insurance plans that provided the company with the highest compensation, rather than offering unbiased comparisons. It is further alleged that SelectQuote received illegal kickbacks from insurers and engaged in discriminatory practices against less profitable beneficiaries, including those with disabilities. The U.S. Department of Justice has filed a complaint against SelectQuote, claiming the company received millions in illegal kickbacks from 2016 to 2021. Following these revelations, SelectQuote's stock price dropped significantly.
AD
Why It's Important?
The allegations against SelectQuote highlight significant ethical and legal concerns within the insurance brokerage industry, particularly regarding the treatment of Medicare beneficiaries. If proven true, these practices could undermine trust in the Medicare Advantage market and lead to increased regulatory scrutiny. The case also underscores the potential financial risks for investors in companies accused of unethical practices. The outcome of this lawsuit could set a precedent for how similar cases are handled in the future, potentially leading to stricter regulations and oversight in the insurance sector. Additionally, the financial impact on SelectQuote and its investors could be substantial, affecting stock prices and investor confidence.
What's Next?
Shareholders interested in participating in the class action must file their papers by October 10, 2025. The lead plaintiff will represent other class members in the litigation process. As the case progresses, it is likely to attract attention from regulatory bodies and could prompt further investigations into similar practices by other companies. The outcome of this lawsuit may influence future regulatory policies and enforcement actions in the insurance industry.
